Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk (Q34516430)

2 August 2017

Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk (English)

1 reference

2 August 2017

Naveed Sattar

9

0 references

Henk J Blom

object named as

Henk J Blom

7

0 references

Rudi Westendorp

5

object named as

Rudi G J Westendorp

1 reference

2 August 2017

10

J Wouter Jukema

1 reference

2 August 2017

6

David J Stott

1 reference

2 August 2017

8

Ian Ford

1 reference

2 August 2017

13

Jacobijn Gussekloo

1 reference

2 August 2017

Yvonne M Drewes

1

1 reference

2 August 2017

Rosalinde K E Poortvliet

2

1 reference

2 August 2017

Jeanet W Blom

3

1 reference

2 August 2017

Wouter de Ruijter

4

1 reference

2 August 2017

Willem J J Assendelft

11

1 reference

2 August 2017

Anton J M de Craen

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

21 January 2014

1 reference

Journal of the American Geriatrics Society

2 August 2017

1 reference

2 August 2017

62

1 reference

2 August 2017

213-221

1 reference

2 August 2017

2

1 reference

Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Screening for future cardiovascular disease using age alone compared with multiple risk factors and age

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine and cardiovascular disease: a review of the evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Facts and recommendations about total homocysteine determinations: an expert opinion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine, B vitamin status, and cognitive function in the elderly

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Calculating the number needed to treat for trials where the outcome is time to an event

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Confidence intervals for the number needed to treat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Total cholesterol and risk of mortality in the oldest old.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Cardiovascular disease risk profiles.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

Homocysteine export from erythrocytes and its implication for plasma sampling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232895

The international pandemic of chronic cardiovascular disease.

7 July 2018

1 reference

Stabilization of homocysteine in unseparated blood over several days: a solution for epidemiological studies

21 January 2018

1 reference

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

21 January 2018

1 reference

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

21 January 2018

1 reference

C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

21 January 2018

1 reference

Change in blood pressure in the age interval 70-90. Late blood pressure peak related to longer survival

21 January 2018

1 reference

12 December 2020

In a population-based prospective study, no association between high blood pressure and mortality after age 85 years

1 reference

12 December 2020

Homocysteine and reclassification of cardiovascular disease risk

1 reference

12 December 2020

Homocysteine and cardiovascular risk an old foe creeps back

1 reference

12 December 2020

Identifiers

DOI

10.1111/JGS.12660

1 reference

release_o6iw3j2xrvbo3dot7g36h66tdm

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o6iw3j2xrvbo3dot7g36h66tdm

24 November 2022

mapped directly with Wikidata item

PMCID

4232895

1 reference

2 August 2017

1 reference